Core Viewpoint - Pediatrix Medical Group (MD) has seen a 4.2% increase in stock price over the past four weeks, closing at 18.21 [1] Price Targets - The mean estimate consists of seven short-term price targets with a standard deviation of 17, while the highest predicts a 44.7% surge to $21 [2][7] - Analysts' price targets can often mislead investors, as empirical research shows that these targets rarely indicate actual stock price movements [5][6] Earnings Estimates - Analysts have shown increasing optimism regarding MD's earnings prospects, with a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [9] - The Zacks Consensus Estimate for the current year has risen by 3.5% over the past month, with four estimates increasing and one decreasing [10] Zacks Rank - MD holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating a strong potential upside in the near term [11] Conclusion on Price Movement - While consensus price targets may not reliably indicate the extent of potential gains, they do provide a useful guide for the direction of price movement [12]
Wall Street Analysts Believe Pediatrix Medical Group (MD) Could Rally 25.5%: Here's is How to Trade